Muscarinic M4 receptor agonist (Cerevel Therapeutics)

N/A

Report date: 2024/06/13 18:05:38
NME

Base Information

Drug NameMuscarinic M4 receptor agonist (Cerevel Therapeutics)
Drug Alias NameM4 agonist (Cerevel Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M4 agonists
TargetsMuscarinic acetylcholine receptor M4
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCerevel Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsMental DisordersNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A